Smith Asset Management Group LP Has $3.69 Million Position in Masimo Corporation (MASI)
Smith Asset Management Group LP lowered its stake in shares of Masimo Corporation (NASDAQ:MASI) by 14.5% during the second quarter, Holdings Channel reports. The institutional investor owned 40,460 shares of the medical equipment provider’s stock after selling 6,886 shares during the period. Smith Asset Management Group LP’s holdings in Masimo Corporation were worth $3,689,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the stock. Neuburgh Advisers LLC boosted its stake in shares of Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 80 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after buying an additional 434 shares in the last quarter. Dubuque Bank & Trust Co. bought a new stake in shares of Masimo Corporation during the first quarter valued at $169,000. Glen Harbor Capital Management LLC boosted its stake in shares of Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock valued at $170,000 after buying an additional 110 shares in the last quarter. Finally, Bancorpsouth Inc. bought a new stake in shares of Masimo Corporation during the first quarter valued at $203,000. Institutional investors own 84.39% of the company’s stock.
Shares of Masimo Corporation (NASDAQ:MASI) opened at 83.58 on Friday. The stock has a market cap of $4.34 billion, a PE ratio of 13.70 and a beta of 0.80. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The firm has a 50-day moving average price of $92.27 and a 200 day moving average price of $89.85.
Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same quarter in the previous year, the business earned $0.57 earnings per share. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. Equities research analysts expect that Masimo Corporation will post $2.80 earnings per share for the current year.
Several equities research analysts recently weighed in on MASI shares. Stifel Nicolaus started coverage on Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 target price for the company. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Zacks Investment Research upgraded Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. Finally, Wedbush reiterated an “outperform” rating and issued a $112.00 price objective on shares of Masimo Corporation in a report on Monday, May 22nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $94.00.
In other Masimo Corporation news, Director Sanford Fitch sold 6,000 shares of the business’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $91.89, for a total transaction of $551,340.00. Following the completion of the transaction, the director now owns 89,249 shares in the company, valued at $8,201,090.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Anand Sampath sold 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at approximately $1,840,000. The disclosure for this sale can be found here. Insiders have sold 115,000 shares of company stock valued at $10,773,180 in the last 90 days. Company insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.